✦ LIBER ✦

A phase I, double-blind, placebo-controlled, randomized, multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of PF 04447943 in mild-to-moderate Alzheimer's disease subjects on stable donepezil therapy

✍ Scribed by Evans, Rebecca; Nicholas, Timothy; Le, Vu; Martin, William; Martin, David; Schwam, Elias

Book ID: 123028567
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 51 KB
Volume: 7
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2011.05.2241

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized, Double-Blind, Placebo-Cont

A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab (AMG 827) in Subjects with Moderate to Severe Asthma

✍ Busse, William W.; Holgate, Stephen T.; Kerwin, Edward M.; Chon, Yun; Feng, Jing 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 38 KB

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre

Mo2083 A Randomized, Double-Blind, Place

Mo2083 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease

✍ Stephan R. Targan; Brian G. Feagan; Severine Vermeire; Remo Panaccione; Gil Y. M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, multiple ascending dose study to evaluate the safety, tolerability and pharmacokinetics of a microtubule stabilizer (BMS-241027) in healthy females

✍ Malamut, Richard; Wang, Jun-Sheng; Savant, Ishani; Xiao, Hong; Sverdlov, Oleksan 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 172 KB

737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND,

737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE ESCALATING ORAL DOSES OF GS-9620 IN HEALTHY SUBJECTS

✍ U. Lopatin; G. Wolfgang; R. Kimberlin; D. Turnas; M. Cornprost; G. Chittick; C. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Randomized, placebo-controlled, double b

Randomized, placebo-controlled, double blind, single- and multiple-dose study to evaluate the pharmacokinetics, safety and tolerability of avagacestat (BMS-708163) in healthy young male and elderly male and female Chinese subjects

✍ Jennifer Karkas; Randy Dockens; Oleksandr Sverdlov; Heather Sevinsky; Bing He; G 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB